Viewing StudyNCT00352079



Ignite Creation Date: 2024-05-05 @ 4:57 PM
Last Modification Date: 2024-10-26 @ 9:26 AM
Study NCT ID: NCT00352079
Status: TERMINATED
Last Update Posted: 2023-08-04
First Post: 2006-07-13

Brief Title: BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
Sponsor: NCIC Clinical Trials Group
Organization: Canadian Cancer Trials Group

Conditions & Keywords Data

Conditions:
Name
Bladder Cancer
Keywords:
Name View
transitional cell carcinoma of the bladder View
stage 0 bladder cancer View
stage I bladder cancer View
recurrent bladder cancer View